PMI — Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement Class III

FDA Device Classification

FDA product code PMI covers "Fluorescence In Situ Hybridization, Platelet-Derived Growth Factor Receptor, Beta Polypeptide (Pdgfrb), Rearrangement", a Class III medical device. Submissions are reviewed by the Unknown panel.

Classification Details

Product Code
PMI
Device Class
Class III
Regulation Number
Submission Type
Review Panel
MG
Medical Specialty
Unknown
Implant
No

Definition

A fluorescence in situ hybridization (FISH) assay for PDGFRB rearrangement is a qualitative in vitro diagnostic assay to detect large rearrangements or translocations within the PDGFRB gene locus. It is indicated as an aid in the assessment of patients for whom treatment with tyrosine kinase inhibitors might be appropriate.